|
| Thursday, January 26, 2023 |
|
|
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating |
| It is reported that Cantor Fitzgerald initiated coverage on Prenetics Global (PRE.US) with "Overweight" rating and target price at USD7.00. more info >> |
|
| Wednesday, January 11, 2023 |
|
|
Prenetics旗下的行动基因的ACTOnco® IVD产品获得FDA许可 成为首家就适用于所有实体肿瘤的癌症基因检测取得许可的亚洲公司 |
| 领先的基因及诊断检测公司Prenetics Global Limited（纳斯达克：PRE）今天宣布，Prenetics近期所收购其多数股权的行动基因已就适用于实体肿瘤的癌症基因检测产品 ACTOnco® IVD (简称： ACTOnco)获得美国食品药物管理局（FDA）的许可。 more info >> |
|
|
Prenetics旗下的行動基因的ACTOnco® IVD產品獲得FDA許可 成為首家就適用於所有實體腫瘤的癌症基因檢測取得許可的亞洲公司 |
| 領先的基因及診斷檢測公司Prenetics Global Limited（納斯達克：PRE）今天宣布，Prenetics近期所收購其多數股權的行動基因已就適用於實體腫瘤的癌症基因檢測產品 ACTOnco® IVD (簡稱： ACTOnco)獲得美國食品藥物管理局（FDA）的許可。 more info >> |
|
|
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors |
| Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced that ACT Genomics, a company which Prenetics recently acquired a majority stake in, has received clearance from the U.S. Food and Drug Administration (FDA) for ACTOnco more info >> |
|
| Friday, December 16, 2022 |
|
|
Prenetics收购行动基因 首次公开招股后首宗并购交易 势扩大癌症基因组学之份额 |
| 全球领先的基因及诊断检测公司Prenetics Global Limited（纳斯达克：PRE）（「Prenetics」或「公司」）将收购行动基因多数股权，预付代价包括19.9百万股Prenetics普通股及2,000万美元现金（「交易」）。 more info >> |
|
|
Prenetics收購行動基因 首次公開招股後首宗並購交易 勢擴大癌症基因組學之份額 |
| 全球領先的基因及診斷檢測公司Prenetics Global Limited（納斯達克：PRE）（「Prenetics」或「公司」）將收購行動基因多數股權，預付代價包括19.9百萬股Prenetics普通股及2,000萬美元現金（「交易」）。 more info >> |
|
|
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics |
| Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, is acquiring a majority stake of ACT, an Asia based genomics company specializing in precision oncology with operations in Hong Kong, Taiwan, Japan, Singapore, Thailand and the UK, for an upfront consideration consisting of 19.9 million shares of Prenetics common stock and US $20 million cash (the "transaction"). more info >> |
|
| Wednesday, November 30, 2022 |
|
|
PRENETICS公布回購計劃 為股東創造長期價值 |
| Prenetics Global (PRE.US)今日公布股份回購計劃。 more info >> |
|
|
Prenetics公布一项2,000万美元股份回购计划及获纳入MSCI全球微型股指数 |
| 全球领先的基因及诊断检测公司Prenetics Global Limited （纳斯达克：PRE）（「Prenetics」或「公司」）今日宣布，公司董事会已授权一项股份回购计划。 more info >> |
|
|
Prenetics公布一項2,000萬美元股份回購計劃及獲納入MSCI全球微型股指數 |
| 全球領先的基因及診斷檢測公司Prenetics Global Limited （納斯達克：PRE）（「Prenetics」或「公司」）今日宣布，公司董事會已授權一項股份回購計劃。 more info >> |
|
|
|
|
